GSK Biologicals

https://www.gsk.com/en-gb/locations/singapore/#tuas-global-vaccines-manufacturing-facility

With an investment of S$510 million, our state-of-the-art vaccines manufacturing facility at Tuas was opened in June 2009 by Singapore's Prime Minister Lee Hsien Loong, coinciding with our 50th anniversary in Singapore.

Comprising two production buildings, an administration block, quality control laboratories, utility plant and warehousing, the facility became operational in 2011. The facility and operations meet the high quality and good manufacturing standards of global regulatory bodies such as the European Medicines Agency.

Tuas is a key manufacturing site within our network supplying the active ingredient used to make our pneumococcal conjugate vaccine. This paediatric vaccine is indicated for the active immunisation against pneumonia caused by Streptococcus pneumoniae, invasive diseases and acute otitis media caused by Streptococcus pneumoniae in infants and children.

Tuas site also focuses on manufacturing Hib (Haemophilus influenzae type b) antigen which is used in the manufacture of several paediatric vaccines. Hib is a bacterium responsible for invasive diseases, such as severe pneumonia and meningitis, contracted almost exclusively by children less than five years old.

These two vaccine products manufactured at Tuas covers approximately 45% of the diseases causing paediatric mortality in the world, making a significant contribution to our global health agenda. The site continues to invest in developing technical capability and process improvement, and embracing new technology such as digital, data and analytics to position itself as the centre of excellence for the manufacture of vaccines.

Tuas has a workforce of more than 500 employees. We are expanding operations at our Tuas site adding new exciting products to our production capabilities and becoming an even more significant part of GSK’s worldwide vaccines supply chain. We are looking for the best and brightest minds to join our teams in uniting science, technology and talent to get ahead of disease together.

Potential career path and developmental opportunities for scholars

GSK needs leaders of the future

The more GSK achieves, the more it knows it has to do. So the next chapter in its story depends on its future leaders. It depends on you.

Make an impact on the world

The scholarship programme is an excellent way for you to develop technical expertise, an advanced understanding of our operations, and an enterprise-wide view of GSK’s business to chart the future of GSK's growth in Singapore and beyond.

GSK will help you to become a leader of the future, equipped to inspire and guide others. Broaden your outlook, deepen your expertise and give yourself the opportunity to make your mark on the healthcare of tomorrow.

Preferred courses of study

• Biological Sciences
• Bioengineering
• Biomedical Engineering
• Chemical & Biomolecular Engineering
• Chemical Engineering
• Chemistry
• Chemistry & Biological Chemistry
• Electrical & Electronic Engineering
• Electrical Engineering
• Electrical Engineering & Information Technology
• Engineering
• Mechanical Engineering
• Pharmaceutical Science